Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Antibe Therapeutics Inc(Pre-Merger) ATBPF

Antibe Therapeutics Inc. is a clinical-stage biotechnology company. The Company is leveraging its hydrogen sulfide (H2S) platform to develop therapies to target inflammation arising from a range of medical conditions. The Company’s pipeline includes assets that seek to overcome the gastrointestinal ulcers and bleeding associated with nonsteroidal anti-inflammatory drugs (NSAIDs). Its lead drug,... see more

GREY:ATBPF - Post Discussion

Antibe Therapeutics Inc(Pre-Merger) > This is much more than "commenced"
View:
Post by Actuarial on Jun 28, 2021 9:26am

This is much more than "commenced"

"we’re now entering confidential discussions for the large markets"
Comment by GameChangerBet on Jun 28, 2021 9:33am
Perhaps they're close to a deal and want to partner up for the start of Phase 3. Could be a reason for the start to be slightly pushed out, buy some more time to finalize a deal. Just speculating between the lines..
Comment by MrMugsy on Jun 28, 2021 9:52am
Yes - I'm sure they would like to conclude an agreement. All depends how many companies are in the running and how far the valuations are from ATE's expected payout. I think you could very quickly get there if two sides can agree to a valuation based on milestone payments, up to and including a successful P3 (where P3 will still be run to Antibe's gameplan). A deal could happen at ...more  
Comment by Arbourmark on Jun 28, 2021 10:35am
The reality the longer this dance with big pharma goes the more ammunition we add to our valuation. It would be in big pharma's best interest to hammer out a deal now versus letting Antibe produce more stellar results. I personally feel another Nuance structured partnership at a higher valuation will be the next big news release.
Comment by GameChangerBet on Jun 28, 2021 10:43am
Definitely. The longer it takes to strike a deal, the more that deal will be worth.  Dan mentioned that very same thing in a recent conversation.  His exact words were: " we will only partner at this stage if it's a good deal ". They know very well the value of the deal by holding out, which is why they did the cash raise.  Raise the cash now to proceed with phase 3 ...more  
Comment by StockingUp21 on Jun 28, 2021 10:21am
zero credibility 
Comment by StockingUp21 on Jun 28, 2021 10:21am
For 100th time they say that.   
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities